APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Oxycodone Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Oxycodone Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174021500330 December 2025190 pages

Choose your research edition.

Industry ResearchOxycodone Drug Industry Research Report 2026148 pages · $2,950 USDIndustry Growth & TrendsGlobal Oxycodone Drug Industry Growth and Trends Forecast to 2032128 pages · $3,450 USDMarket StructureGlobal Oxycodone Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oxycodone Drug Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Oxycodone Drug Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global Oxycodone Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Oxycodone Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Oxycodone Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oxycodone Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Oxycodone Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Oxycodone Drug include Endone, Endone, Hikma Pharmaceuticals USA, Hikma Pharmaceuticals USA, Janssen Pharmaceuticals(Johnson & Johnson), OxyContin, OxyContin, Oxynorm and Oxynorm, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Oxycodone Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Oxycodone Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Oxycodone Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Oxycodone Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Oxycodone Drug Segment by Company

Endone

Endone

Hikma Pharmaceuticals USA

Hikma Pharmaceuticals USA

Janssen Pharmaceuticals(Johnson & Johnson)

OxyContin

OxyContin

Oxynorm

Oxynorm

Proladone

Proladone

Purdue Pharma L.P

Purdue Pharma L.P

Sanofi-Aventis S.A.

Sanofi-Aventis S.A.

Sun Pharmaceutical Industries Ltd.

Targin

Targin

Pfizer

Pfizer

Sun Pharmaceutical Industries Ltd.

Janssen Pharmaceuticals(Johnson & Johnson)

Oxycodone Drug Segment by Type

Anesthesia

Anesthesia

Others

Pain Management

Pain Management

Others

Oxycodone Drug Segment by Application

Ambulatory Surgical Centers (ASCs)

Ambulatory Surgical Centers (ASCs)

Hospitals & Clinics

Hospitals & Clinics

Oxycodone Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oxycodone Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oxycodone Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oxycodone Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Oxycodone Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oxycodone Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Oxycodone Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Oxycodone Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Oxycodone Drug Industry Trends Table 2. Oxycodone Drug Industry Drivers Table 3. Oxycodone Drug Industry Opportunities and Challenges Table 4. Oxycodone Drug Industry Restraints Table 5. Global Oxycodone Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Oxycodone Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Oxycodone Drug Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Oxycodone Drug Sales Market Share by Manufacturers Table 9. Global Oxycodone Drug Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Oxycodone Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Oxycodone Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Oxycodone Drug Manufacturers, Product Type & Application Table 13. Global Oxycodone Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Oxycodone Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Anesthesia Table 17. Major Manufacturers of Anesthesia Table 18. Major Manufacturers of Others Table 19. Major Manufacturers of Pain Management Table 20. Major Manufacturers of Pain Management Table 21. Major Manufacturers of Others Table 22. Global Oxycodone Drug Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global Oxycodone Drug Sales by Type (2021-2026) & (K Units) Table 24. Global Oxycodone Drug Sales by Type (2027-2032) & (K Units) Table 25. Global Oxycodone Drug Sales Market Share by Type (2021-2026) Table 26. Global Oxycodone Drug Sales Market Share by Type (2027-2032) Table 27. Global Oxycodone Drug Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 28. Global Oxycodone Drug Revenue by Type (2021-2026) & (K Units) Table 29. Global Oxycodone Drug Revenue by Type (2027-2032) & (K Units) Table 30. Global Oxycodone Drug Revenue Market Share by Type (2021-2026) Table 31. Global Oxycodone Drug Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Ambulatory Surgical Centers (ASCs) Table 33. Major Manufacturers of Ambulatory Surgical Centers (ASCs) Table 34. Major Manufacturers of Hospitals & Clinics Table 35. Major Manufacturers of Hospitals & Clinics Table 36. Global Oxycodone Drug Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Oxycodone Drug Sales by Application (2021-2026) & (K Units) Table 38. Global Oxycodone Drug Sales by Application (2027-2032) & (K Units) Table 39. Global Oxycodone Drug Sales Market Share by Application (2021-2026) Table 40. Global Oxycodone Drug Sales Market Share by Application (2027-2032) Table 41. Global Oxycodone Drug Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 42. Global Oxycodone Drug Revenue by Application (2021-2026) & (K Units) Table 43. Global Oxycodone Drug Revenue by Application (2027-2032) & (K Units) Table 44. Global Oxycodone Drug Revenue Market Share by Application (2021-2026) Table 45. Global Oxycodone Drug Revenue Market Share by Application (2027-2032) Table 46. Global Oxycodone Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 47. Global Oxycodone Drug Sales by Region (2021-2026) & (K Units) Table 48. Global Oxycodone Drug Sales Market Share by Region (2021-2026) Table 49. Global Oxycodone Drug Sales Forecasted by Region (2027-2032) & (K Units) Table 50. Global Oxycodone Drug Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Oxycodone Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. North America Oxycodone Drug Sales by Country (2021-2026) & (K Units) Table 53. North America Oxycodone Drug Sales by Country (2027-2032) & (K Units) Table 54. Europe Oxycodone Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Europe Oxycodone Drug Sales by Country (2021-2026) & (K Units) Table 56. Europe Oxycodone Drug Sales by Country (2027-2032) & (K Units) Table 57. Asia Pacific Oxycodone Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Asia Pacific Oxycodone Drug Sales by Country (2021-2026) & (K Units) Table 59. Asia Pacific Oxycodone Drug Sales by Country (2027-2032) & (K Units) Table 60. South America, Middle East and Africa Oxycodone Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 61. South America, Middle East and Africa Oxycodone Drug Sales by Country (2021-2026) & (K Units) Table 62. South America, Middle East and Africa Oxycodone Drug Sales by Country (2027-2032) & (K Units) Table 63. Global Oxycodone Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Oxycodone Drug Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Oxycodone Drug Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Oxycodone Drug Revenue Market Share by Region (2021-2026) Table 67. Global Oxycodone Drug Revenue Market Share by Region (2027-2032) Table 68. Endone Company Information Table 69. Endone Business Overview Table 70. Endone Oxycodone Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Endone Oxycodone Drug Product Portfolio Table 72. Endone Recent Development Table 73. Endone Company Information Table 74. Endone Business Overview Table 75. Endone Oxycodone Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Endone Oxycodone Drug Product Portfolio Table 77. Endone Recent Development Table 78. Hikma Pharmaceuticals USA Company Information Table 79. Hikma Pharmaceuticals USA Business Overview Table 80. Hikma Pharmaceuticals USA Oxycodone Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Hikma Pharmaceuticals USA Oxycodone Drug Product Portfolio Table 82. Hikma Pharmaceuticals USA Recent Development Table 83. Hikma Pharmaceuticals USA Company Information Table 84. Hikma Pharmaceuticals USA Business Overview Table 85. Hikma Pharmaceuticals USA Oxycodone Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Hikma Pharmaceuticals USA Oxycodone Drug Product Portfolio Table 87. Hikma Pharmaceuticals USA Recent Development Table 88. Janssen Pharmaceuticals(Johnson & Johnson) Company Information Table 89. Janssen Pharmaceuticals(Johnson & Johnson) Business Overview Table 90. Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Product Portfolio Table 92. Janssen Pharmaceuticals(Johnson & Johnson) Recent Development Table 93. OxyContin Company Information Table 94. OxyContin Business Overview Table 95. OxyContin Oxycodone Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. OxyContin Oxycodone Drug Product Portfolio Table 97. OxyContin Recent Development Table 98. OxyContin Company Information Table 99. OxyContin Business Overview Table 100. OxyContin Oxycodone Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. OxyContin Oxycodone Drug Product Portfolio Table 102. OxyContin Recent Development Table 103. Oxynorm Company Information Table 104. Oxynorm Business Overview Table 105. Oxynorm Oxycodone Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Oxynorm Oxycodone Drug Product Portfolio Table 107. Oxynorm Recent Development Table 108. Oxynorm Company Information Table 109. Oxynorm Business Overview Table 110. Oxynorm Oxycodone Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Oxynorm Oxycodone Drug Product Portfolio Table 112. Oxynorm Recent Development Table 113. Proladone Company Information Table 114. Proladone Business Overview Table 115. Proladone Oxycodone Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Proladone Oxycodone Drug Product Portfolio Table 117. Proladone Recent Development Table 118. Proladone Company Information Table 119. Proladone Business Overview Table 120. Proladone Oxycodone Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Proladone Oxycodone Drug Product Portfolio Table 122. Proladone Recent Development Table 123. Purdue Pharma L.P Company Information Table 124. Purdue Pharma L.P Business Overview Table 125. Purdue Pharma L.P Oxycodone Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Purdue Pharma L.P Oxycodone Drug Product Portfolio Table 127. Purdue Pharma L.P Recent Development Table 128. Purdue Pharma L.P Company Information Table 129. Purdue Pharma L.P Business Overview Table 130. Purdue Pharma L.P Oxycodone Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Purdue Pharma L.P Oxycodone Drug Product Portfolio Table 132. Purdue Pharma L.P Recent Development Table 133. Sanofi-Aventis S.A. Company Information Table 134. Sanofi-Aventis S.A. Business Overview Table 135. Sanofi-Aventis S.A. Oxycodone Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Sanofi-Aventis S.A. Oxycodone Drug Product Portfolio Table 137. Sanofi-Aventis S.A. Recent Development Table 138. Sanofi-Aventis S.A. Company Information Table 139. Sanofi-Aventis S.A. Business Overview Table 140. Sanofi-Aventis S.A. Oxycodone Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Sanofi-Aventis S.A. Oxycodone Drug Product Portfolio Table 142. Sanofi-Aventis S.A. Recent Development Table 143. Sun Pharmaceutical Industries Ltd. Company Information Table 144. Sun Pharmaceutical Industries Ltd. Business Overview Table 145. Sun Pharmaceutical Industries Ltd. Oxycodone Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Sun Pharmaceutical Industries Ltd. Oxycodone Drug Product Portfolio Table 147. Sun Pharmaceutical Industries Ltd. Recent Development Table 148. Targin Company Information Table 149. Targin Business Overview Table 150. Targin Oxycodone Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. Targin Oxycodone Drug Product Portfolio Table 152. Targin Recent Development Table 153. Targin Company Information Table 154. Targin Business Overview Table 155. Targin Oxycodone Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 156. Targin Oxycodone Drug Product Portfolio Table 157. Targin Recent Development Table 158. Pfizer Company Information Table 159. Pfizer Business Overview Table 160. Pfizer Oxycodone Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 161. Pfizer Oxycodone Drug Product Portfolio Table 162. Pfizer Recent Development Table 163. Pfizer Company Information Table 164. Pfizer Business Overview Table 165. Pfizer Oxycodone Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 166. Pfizer Oxycodone Drug Product Portfolio Table 167. Pfizer Recent Development Table 168. Sun Pharmaceutical Industries Ltd. Company Information Table 169. Sun Pharmaceutical Industries Ltd. Business Overview Table 170. Sun Pharmaceutical Industries Ltd. Oxycodone Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 171. Sun Pharmaceutical Industries Ltd. Oxycodone Drug Product Portfolio Table 172. Sun Pharmaceutical Industries Ltd. Recent Development Table 173. Janssen Pharmaceuticals(Johnson & Johnson) Company Information Table 174. Janssen Pharmaceuticals(Johnson & Johnson) Business Overview Table 175. Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 176. Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Product Portfolio Table 177. Janssen Pharmaceuticals(Johnson & Johnson) Recent Development Table 178. Key Raw Materials Table 179. Raw Materials Key Suppliers Table 180. Oxycodone Drug Distributors List Table 181. Oxycodone Drug Customers List Table 182. Research Programs/Design for This Report Table 183. Authors List of This Report Table 184. Secondary Sources Table 185. Primary Sources List of Figures Figure 1. Oxycodone Drug Product Image Figure 2. Global Oxycodone Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oxycodone Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Oxycodone Drug Sales (2021-2032) & (K Units) Figure 5. Global Oxycodone Drug Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Oxycodone Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Anesthesia Image Figure 9. Anesthesia Image Figure 10. Others Image Figure 11. Pain Management Image Figure 12. Pain Management Image Figure 13. Others Image Figure 14. Global Oxycodone Drug Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Oxycodone Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global Oxycodone Drug Sales Market Share by Type (2021-2032) Figure 17. Global Oxycodone Drug Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 18. Global Oxycodone Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Oxycodone Drug Revenue Market Share by Type (2021-2032) Figure 20. Ambulatory Surgical Centers (ASCs) Image Figure 21. Ambulatory Surgical Centers (ASCs) Image Figure 22. Hospitals & Clinics Image Figure 23. Hospitals & Clinics Image Figure 24. Global Oxycodone Drug Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Oxycodone Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Oxycodone Drug Sales Market Share by Application (2021-2032) Figure 27. Global Oxycodone Drug Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 28. Global Oxycodone Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Oxycodone Drug Revenue Market Share by Application (2021-2032) Figure 30. North America Oxycodone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 31. North America Oxycodone Drug Sales Market Share by Country (2021-2032) Figure 32. U.S. Oxycodone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Canada Oxycodone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Mexico Oxycodone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Europe Oxycodone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Europe Oxycodone Drug Sales Market Share by Country (2021-2032) Figure 37. Germany Oxycodone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 38. France Oxycodone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 39. U.K. Oxycodone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Italy Oxycodone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Netherlands Oxycodone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Asia Pacific Oxycodone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Asia Pacific Oxycodone Drug Sales Market Share by Country (2021-2032) Figure 44. China Oxycodone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Japan Oxycodone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South Korea Oxycodone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Southeast Asia Oxycodone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 48. India Oxycodone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Australia Oxycodone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South America, Middle East and Africa Oxycodone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South America, Middle East and Africa Oxycodone Drug Sales Market Share by Country (2021-2032) Figure 52. Brazil Oxycodone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 53. South Africa Oxycodone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Saudi Arabia Oxycodone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Turkey Oxycodone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Argentina Oxycodone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 57. UAE Oxycodone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Egypt Oxycodone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Chile Oxycodone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 60. Global Oxycodone Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Oxycodone Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Oxycodone Drug Revenue (2021-2032) & (US$ Million) Figure 63. North America Oxycodone Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Oxycodone Drug Revenue (2021-2032) & (US$ Million) Figure 65. Europe Oxycodone Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Oxycodone Drug Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Oxycodone Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Oxycodone Drug Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Oxycodone Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Oxycodone Drug Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Oxycodone Drug Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Anesthesia
  • Anesthesia
  • Others
  • Pain Management
  • Pain Management
  • Others
Applications
  • Ambulatory Surgical Centers (ASCs)
  • Ambulatory Surgical Centers (ASCs)
  • Hospitals & Clinics
  • Hospitals & Clinics
Companies covered
  • Endone
  • Endone
  • Hikma Pharmaceuticals USA
  • Hikma Pharmaceuticals USA
  • Janssen Pharmaceuticals(Johnson & Johnson)
  • OxyContin
  • OxyContin
  • Oxynorm
  • Oxynorm
  • Proladone
  • Proladone
  • Purdue Pharma L.P
  • Purdue Pharma L.P
  • Sanofi-Aventis S.A.
  • Sanofi-Aventis S.A.
  • Sun Pharmaceutical Industries Ltd.
  • Targin
  • Targin
  • Pfizer
  • Pfizer
  • Sun Pharmaceutical Industries Ltd.
  • Janssen Pharmaceuticals(Johnson & Johnson)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Oxycodone Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Oxycodone Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Oxycodone Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Oxycodone Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Oxycodone Drug Market Dynamics
  1. 2.1 Oxycodone Drug Industry Trends
  2. 2.2 Oxycodone Drug Industry Drivers
  3. 2.3 Oxycodone Drug Industry Opportunities and Challenges
  4. 2.4 Oxycodone Drug Industry Restraints
3 Oxycodone Drug Market by Manufacturers
  1. 3.1 Global Oxycodone Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Oxycodone Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Oxycodone Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Oxycodone Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Oxycodone Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Oxycodone Drug Manufacturers, Product Type & Application
  7. 3.7 Global Oxycodone Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Oxycodone Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Oxycodone Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Oxycodone Drug Tier 1, Tier 2, and Tier 3
4 Oxycodone Drug Market by Type
  1. 4.1 Oxycodone Drug Type Introduction
  2. 4.1.1 Anesthesia
  3. 4.1.2 Anesthesia
  4. 4.1.3 Others
  5. 4.1.4 Pain Management
  6. 4.1.5 Pain Management
  7. 4.1.6 Others
  8. 4.2 Global Oxycodone Drug Sales by Type
  9. 4.2.1 Global Oxycodone Drug Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Oxycodone Drug Sales by Type (2021-2032)
  11. 4.2.3 Global Oxycodone Drug Sales Market Share by Type (2021-2032)
  12. 4.3 Global Oxycodone Drug Revenue by Type
  13. 4.3.1 Global Oxycodone Drug Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Oxycodone Drug Revenue by Type (2021-2032)
  15. 4.3.3 Global Oxycodone Drug Revenue Market Share by Type (2021-2032)
5 Oxycodone Drug Market by Application
  1. 5.1 Oxycodone Drug Application Introduction
  2. 5.1.1 Ambulatory Surgical Centers (ASCs)
  3. 5.1.2 Ambulatory Surgical Centers (ASCs)
  4. 5.1.3 Hospitals & Clinics
  5. 5.1.4 Hospitals & Clinics
  6. 5.2 Global Oxycodone Drug Sales by Application
  7. 5.2.1 Global Oxycodone Drug Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Oxycodone Drug Sales by Application (2021-2032)
  9. 5.2.3 Global Oxycodone Drug Sales Market Share by Application (2021-2032)
  10. 5.3 Global Oxycodone Drug Revenue by Application
  11. 5.3.1 Global Oxycodone Drug Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Oxycodone Drug Revenue by Application (2021-2032)
  13. 5.3.3 Global Oxycodone Drug Revenue Market Share by Application (2021-2032)
6 Global Oxycodone Drug Sales by Region
  1. 6.1 Global Oxycodone Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Oxycodone Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Oxycodone Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Oxycodone Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Oxycodone Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Oxycodone Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Oxycodone Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Oxycodone Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Oxycodone Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Oxycodone Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Oxycodone Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Oxycodone Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Oxycodone Drug Revenue by Region
  1. 7.1 Global Oxycodone Drug Revenue by Region
  2. 7.1.1 Global Oxycodone Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Oxycodone Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Oxycodone Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Oxycodone Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Oxycodone Drug Revenue (2021-2032)
  8. 7.2.2 North America Oxycodone Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Oxycodone Drug Revenue (2021-2032)
  11. 7.3.2 Europe Oxycodone Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Oxycodone Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Oxycodone Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Oxycodone Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Oxycodone Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Endone
  2. 8.1.1 Endone Company Information
  3. 8.1.2 Endone Business Overview
  4. 8.1.3 Endone Oxycodone Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Endone Oxycodone Drug Product Portfolio
  6. 8.1.5 Endone Recent Developments
  7. 8.2 Endone
  8. 8.2.1 Endone Company Information
  9. 8.2.2 Endone Business Overview
  10. 8.2.3 Endone Oxycodone Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Endone Oxycodone Drug Product Portfolio
  12. 8.2.5 Endone Recent Developments
  13. 8.3 Hikma Pharmaceuticals USA
  14. 8.3.1 Hikma Pharmaceuticals USA Company Information
  15. 8.3.2 Hikma Pharmaceuticals USA Business Overview
  16. 8.3.3 Hikma Pharmaceuticals USA Oxycodone Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Hikma Pharmaceuticals USA Oxycodone Drug Product Portfolio
  18. 8.3.5 Hikma Pharmaceuticals USA Recent Developments
  19. 8.4 Hikma Pharmaceuticals USA
  20. 8.4.1 Hikma Pharmaceuticals USA Company Information
  21. 8.4.2 Hikma Pharmaceuticals USA Business Overview
  22. 8.4.3 Hikma Pharmaceuticals USA Oxycodone Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Hikma Pharmaceuticals USA Oxycodone Drug Product Portfolio
  24. 8.4.5 Hikma Pharmaceuticals USA Recent Developments
  25. 8.5 Janssen Pharmaceuticals(Johnson & Johnson)
  26. 8.5.1 Janssen Pharmaceuticals(Johnson & Johnson) Company Information
  27. 8.5.2 Janssen Pharmaceuticals(Johnson & Johnson) Business Overview
  28. 8.5.3 Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Product Portfolio
  30. 8.5.5 Janssen Pharmaceuticals(Johnson & Johnson) Recent Developments
  31. 8.6 OxyContin
  32. 8.6.1 OxyContin Company Information
  33. 8.6.2 OxyContin Business Overview
  34. 8.6.3 OxyContin Oxycodone Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 OxyContin Oxycodone Drug Product Portfolio
  36. 8.6.5 OxyContin Recent Developments
  37. 8.7 OxyContin
  38. 8.7.1 OxyContin Company Information
  39. 8.7.2 OxyContin Business Overview
  40. 8.7.3 OxyContin Oxycodone Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 OxyContin Oxycodone Drug Product Portfolio
  42. 8.7.5 OxyContin Recent Developments
  43. 8.8 Oxynorm
  44. 8.8.1 Oxynorm Company Information
  45. 8.8.2 Oxynorm Business Overview
  46. 8.8.3 Oxynorm Oxycodone Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Oxynorm Oxycodone Drug Product Portfolio
  48. 8.8.5 Oxynorm Recent Developments
  49. 8.9 Oxynorm
  50. 8.9.1 Oxynorm Company Information
  51. 8.9.2 Oxynorm Business Overview
  52. 8.9.3 Oxynorm Oxycodone Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Oxynorm Oxycodone Drug Product Portfolio
  54. 8.9.5 Oxynorm Recent Developments
  55. 8.10 Proladone
  56. 8.10.1 Proladone Company Information
  57. 8.10.2 Proladone Business Overview
  58. 8.10.3 Proladone Oxycodone Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Proladone Oxycodone Drug Product Portfolio
  60. 8.10.5 Proladone Recent Developments
  61. 8.11 Proladone
  62. 8.11.1 Proladone Company Information
  63. 8.11.2 Proladone Business Overview
  64. 8.11.3 Proladone Oxycodone Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Proladone Oxycodone Drug Product Portfolio
  66. 8.11.5 Proladone Recent Developments
  67. 8.12 Purdue Pharma L.P
  68. 8.12.1 Purdue Pharma L.P Company Information
  69. 8.12.2 Purdue Pharma L.P Business Overview
  70. 8.12.3 Purdue Pharma L.P Oxycodone Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Purdue Pharma L.P Oxycodone Drug Product Portfolio
  72. 8.12.5 Purdue Pharma L.P Recent Developments
  73. 8.13 Purdue Pharma L.P
  74. 8.13.1 Purdue Pharma L.P Company Information
  75. 8.13.2 Purdue Pharma L.P Business Overview
  76. 8.13.3 Purdue Pharma L.P Oxycodone Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Purdue Pharma L.P Oxycodone Drug Product Portfolio
  78. 8.13.5 Purdue Pharma L.P Recent Developments
  79. 8.14 Sanofi-Aventis S.A.
  80. 8.14.1 Sanofi-Aventis S.A. Company Information
  81. 8.14.2 Sanofi-Aventis S.A. Business Overview
  82. 8.14.3 Sanofi-Aventis S.A. Oxycodone Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Sanofi-Aventis S.A. Oxycodone Drug Product Portfolio
  84. 8.14.5 Sanofi-Aventis S.A. Recent Developments
  85. 8.15 Sanofi-Aventis S.A.
  86. 8.15.1 Sanofi-Aventis S.A. Company Information
  87. 8.15.2 Sanofi-Aventis S.A. Business Overview
  88. 8.15.3 Sanofi-Aventis S.A. Oxycodone Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Sanofi-Aventis S.A. Oxycodone Drug Product Portfolio
  90. 8.15.5 Sanofi-Aventis S.A. Recent Developments
  91. 8.16 Sun Pharmaceutical Industries Ltd.
  92. 8.16.1 Sun Pharmaceutical Industries Ltd. Company Information
  93. 8.16.2 Sun Pharmaceutical Industries Ltd. Business Overview
  94. 8.16.3 Sun Pharmaceutical Industries Ltd. Oxycodone Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Sun Pharmaceutical Industries Ltd. Oxycodone Drug Product Portfolio
  96. 8.16.5 Sun Pharmaceutical Industries Ltd. Recent Developments
  97. 8.17 Targin
  98. 8.17.1 Targin Company Information
  99. 8.17.2 Targin Business Overview
  100. 8.17.3 Targin Oxycodone Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Targin Oxycodone Drug Product Portfolio
  102. 8.17.5 Targin Recent Developments
  103. 8.18 Targin
  104. 8.18.1 Targin Company Information
  105. 8.18.2 Targin Business Overview
  106. 8.18.3 Targin Oxycodone Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Targin Oxycodone Drug Product Portfolio
  108. 8.18.5 Targin Recent Developments
  109. 8.19 Pfizer
  110. 8.19.1 Pfizer Company Information
  111. 8.19.2 Pfizer Business Overview
  112. 8.19.3 Pfizer Oxycodone Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Pfizer Oxycodone Drug Product Portfolio
  114. 8.19.5 Pfizer Recent Developments
  115. 8.20 Pfizer
  116. 8.20.1 Pfizer Company Information
  117. 8.20.2 Pfizer Business Overview
  118. 8.20.3 Pfizer Oxycodone Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Pfizer Oxycodone Drug Product Portfolio
  120. 8.20.5 Pfizer Recent Developments
  121. 8.21 Sun Pharmaceutical Industries Ltd.
  122. 8.21.1 Sun Pharmaceutical Industries Ltd. Company Information
  123. 8.21.2 Sun Pharmaceutical Industries Ltd. Business Overview
  124. 8.21.3 Sun Pharmaceutical Industries Ltd. Oxycodone Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Sun Pharmaceutical Industries Ltd. Oxycodone Drug Product Portfolio
  126. 8.21.5 Sun Pharmaceutical Industries Ltd. Recent Developments
  127. 8.22 Janssen Pharmaceuticals(Johnson & Johnson)
  128. 8.22.1 Janssen Pharmaceuticals(Johnson & Johnson) Company Information
  129. 8.22.2 Janssen Pharmaceuticals(Johnson & Johnson) Business Overview
  130. 8.22.3 Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Product Portfolio
  132. 8.22.5 Janssen Pharmaceuticals(Johnson & Johnson) Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Oxycodone Drug Value Chain Analysis
  2. 9.1.1 Oxycodone Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Oxycodone Drug Production Mode & Process
  6. 9.2 Oxycodone Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Oxycodone Drug Distributors
  9. 9.2.3 Oxycodone Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst